Drug Delivery

In this white paper, we report the use of the thermal stability data obtained from DSC to screen conditions for viral inactivation of an antibody1.

See how thermodynamics can be used to improve your lead optimization process.

Protein interactions define a large fraction of the validated targets for drug development including cancer, diabetes, infection and autoimmune diseases.

In an industry as diverse as pharmaceuticals, there is much that different disciplines can learn from each another.

Could an ionic liquid–drug system help solve drug insolubility?

How to dress drugs to help them survive in the bloodstream.

Can lettuce really help biopharmaceuticals turn over a new leaf? Researchers certainly think so.

In this report, we illustrate the utility of calorimetry in making better laboratory decisions.

A case study involving the formulation development of a monoclonal antibody is presented to detail the utility and potential limitations of DSC in support of preformulation for a variety of protein products.

In Part Four, we address frequently asked questions related to the application of DLS to the characterization of protein therapeutic formulations.